Endothelial Cell Metabolism: A potential target to improve tumor immunity

Olivia Lisa Wagman, Julie Nelly Christensen, Joanna Maria Kalucka*

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

2 Citations (Scopus)
67 Downloads (Pure)

Abstract

Failure of current therapies to eliminate tumors is, in part, due to inadequate infiltration of immune cells. The importance of endothelial cells for the induction of immune responses is now being recognized. However, tumor endothelial cells (TECs) are dysfunctional, leading to decreased tumor immunity. Because TEC metabolism contributes to the abnormal vascular phenotype, interest is growing in the tumor vasculature as a target to improve immune responses. Recent insights into the relationship between TEC metabolism and immunity suggest that normalization of the tumor vasculature through metabolic reprogramming could be an important tool to improve immune-based anti-cancer therapies.

Original languageEnglish
Article number100376
JournalCurrent Opinion in Systems Biology
Volume28
ISSN2452-3100
DOIs
Publication statusPublished - Dec 2021

Keywords

  • Activation
  • Cancer
  • Endothelial cells
  • Immunoregulation
  • Inflammation
  • Metabolism

Fingerprint

Dive into the research topics of 'Endothelial Cell Metabolism: A potential target to improve tumor immunity'. Together they form a unique fingerprint.

Cite this